We have shown earlier using the transwell assay (Kaucká et al., 2013) that the migration of CLL cells can be inhibited both by inhibitors of casein kinase 1 (CK1) and by inhibitors of the RhoA–Rho-associated kinase (ROCK) axis. This evidence concerns the gene RHOA and B-cell chronic lymphocytic leukemia.